Terrific briefing with MPs and peers on our support of the UK diagnostics industry during the pandemic, and beyond. ๐จโโ๏ธ๐ฉโโ๏ธ
Huge achievements. Increased production capacity of LFD in the UK by over 3000% in less than a year.
More to do. ๐
๐งต1/.
INVESTMENT: Transformed three UK manufacturers and supported approval of multiple UK LFD COVID-19 tests.
cยฃ300m in direct and indirect investment that has transformed the operations of SureScreen, GAD and Omega. Secured ~92m ๐ฌ๐ง-made tests and created a lasting legacy. ๐งต2/-
LEGACY: Increased production capacity by over 3500% in >1yr. From ~400K to ~15m tests pw. Capacity will be ~20m per week by the end of 2021.
๐ฌ๐ง will have a high-volume, high-speed, automated production capacity able to support HMG and patients for years to come. ๐งต3/
INVESTMENT: Working with industry partners we have delivered ยฃ40m in direct investment, provided specialist manufacturing engineering expertise to transform production performance and a whole bunch more. See below for our approach. ๐งต4/
INNOVATION: improving clinical performance (via antibody assessment and prototyping initiative), and design of more usable and sustainable product. ๐
Eg Developed new packaging design with 30% less materials capable of reducing waste by 15,000 tonnes per year. (pic below)๐ณ๐งต5/
VALIDATION: we have high standards and apply them rigorously.
Porton Down's run 146 Phase 2 "futility" tests and phase 2aโs of which 42% have passed. 58 "3a" validations with 37 passes (64%).
All passed VoC testing (Alpha, Beta, Gamma, Delta). ๐งต6/.
#leadingtheworld ๐ฌ๐ง
๐๐ to "UK MAKE" team and all partners for delivery of specialist support covering (1) production equipment, (2) fabrication and installation, (3) manufacturing engineering, (4) clinical and regulatory approvals, (5) commercial and procurement, and (6) programme management. End
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.